Common use of License Grant Upon Exercise Clause in Contracts

License Grant Upon Exercise. If Licensee exercises the Commercial Option for a particular Disease Indication, effective upon Licensor’s receipt of the notice and, if applicable, fee described in Section 2.3.1 (the “Grant Date” for such Disease Indication with respect to the applicable Specified Vector), subject to the terms and conditions of this Agreement, including the Retained Rights, Licensor shall be deemed to have granted to Licensee a non-exclusive, sublicensable (as provided in Section 2.6 only), non-transferable (except as provided in Section 10.2), royalty-bearing, worldwide license under the applicable Licensed Commercial Patents to make, have made, use, import, sell, and offer for sale Licensed Products using the Specified Vector solely in the Commercial Field of such Disease Indication, including, for the avoidance of doubt, the right to conduct research and development.

Appears in 3 contracts

Samples: License Agreement (Adverum Biotechnologies, Inc.), License Agreement (REGENXBIO Inc.), License Agreement (REGENXBIO Inc.)

AutoNDA by SimpleDocs

License Grant Upon Exercise. If Licensee exercises the Commercial Additional Indication Option for a particular Additional Disease IndicationIndication by providing the written notice described in Section 2.3.2, effective upon Licensor’s receipt of the notice and, if applicable, fee described in Section 2.3.1 2.3.2 (the “Grant Date” for such Additional Disease Indication with respect to the applicable Specified VectorIndication), subject to the terms and conditions of this Agreement, including the Retained Rights, Licensor shall be deemed to have granted to Licensee a non-an exclusive, sublicensable (as provided in Section 2.6 only), non-transferable (except as provided in Section 10.2), royalty-bearing, worldwide license under the applicable Licensed Commercial Patents to make, have made, use, import, sell, and offer for sale Licensed Products using the Specified Vector solely in the Commercial Field of such Additional Disease Indication, including, for the avoidance of doubt, the right to conduct research and development.

Appears in 2 contracts

Samples: License Agreement (Audentes Therapeutics, Inc.), License Agreement (Audentes Therapeutics, Inc.)

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.